Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
02/2015
02/18/2015EP2836212A1 Novel compositions and methods
02/18/2015EP2836211A1 Novel methods
02/18/2015EP2836210A2 An agent for inducing the synthesis of heat-shock proteins in human and animal cells; a cosmetic preparation for enhancing reparative processes; a cosmetic preparation for reducing side effects of aggressive cosmetic procedures; a food supplement; a foodstuff; a method of reducing side effects of aggressive cosmetic procedures
02/18/2015EP2836209A1 Method for treating hyperuricemia in patients with gout using halofenate or halofenic acid and an anti-inflammatory agent
02/18/2015EP2836208A1 Composition for the treatment of inflammatory and immune disorders
02/18/2015EP2836206A2 Controlled release pharmaceutical formulations of direct thrombin inhibitors
02/18/2015EP2836204A1 Aggregate particles
02/18/2015EP2836203A1 Vesicular formulations for use in the treatment of pain or reduced mobility of a joint
02/18/2015EP2836202A1 Pharmaceutical composition containing an unsaturated fatty acid enriched with oxygen and an organic solvent
02/18/2015EP2836201A1 Modified release liquid pharmaceutical composition comprising bromopheniramine, pseudoephedrine and dextromethorphan
02/18/2015EP2836199A1 Fulvestrant formulations
02/18/2015EP2836198A2 Pharmaceutical composition comprising arformoterol and fluticasone furoate
02/18/2015EP2836197A1 Oral film containing opiate enteric-release beads
02/18/2015EP2836196A1 Preparation for topical application to mucosa containing polyhexanide as active ingredient
02/18/2015EP2836190A2 Cosmetic and pharmaceutical uses of saccharides
02/18/2015EP2836071A1 Composition for the treatment of pediculosis and corresponding manufacturing process
02/17/2015US8957223 Ligand-conjugated monomers
02/17/2015US8957219 Acetic acid amide derivative having inhibitory activity on endothelial lipase
02/17/2015US8957218 2-oxo-1-imidazolidinyl imidazothiadiazole derivatives
02/17/2015US8957213 Ethynyl compounds
02/17/2015US8957209 Methods for the synthesis of tiotropium bromide
02/17/2015US8957203 Hepatitis C virus inhibitors
02/17/2015US8957200 Bicyclic nucleosides and oligomeric compounds prepared therefrom
02/17/2015US8957198 Compositions, devices and methods for treatment of Huntington's disease through intracranial delivery of sirna
02/17/2015US8957115 Pheromone compositions and methods of use
02/17/2015US8957114 Formulations, salts and polymorphs of transnorsertraline and uses thereof
02/17/2015US8957113 Tranexamic acid formulations
02/17/2015US8957112 Cream gels comprising at least one retinoid and benzoyl peroxide
02/17/2015US8957111 Strontium (M) ascorbate, compositions containing same, method for making same and method of using same
02/17/2015US8957110 Ophthalmic compositions based on polyunsaturated omega-3 and omega-6 fatty acids
02/17/2015US8957109 Chroman derivatives, medicaments and use in therapy
02/17/2015US8957108 Use of 5,6-dimethylxanthenone-4-acetic acid as an antiviral agent
02/17/2015US8957107 Method of treating scars and β-catenin-mediated disorders using Nefopam compounds
02/17/2015US8957106 Iminosugar treatment of tumors
02/17/2015US8957104 Chemical compounds
02/17/2015US8957103 Conjugated 3-(indolyl)- and 3-(azaindolyl)-4-arylmaleimide compounds and their use in tumor treatment
02/17/2015US8957102 Heterocyclic compound as protein kinase inhibitor
02/17/2015US8957101 Amino acid compositions
02/17/2015US8957100 Amino acid compositions
02/17/2015US8957099 Treatment of ADHD
02/17/2015US8957098 Use of leflunomide and malononitrilamides
02/17/2015US8957097 Hemi-phorboxazole A derivatives and methods of their use
02/17/2015US8957095 Treatment of sunburn using analgesics and antihistamines
02/17/2015US8957094 Therapeutic agent or prophylactic agent for fibromyalgia
02/17/2015US8957093 N-biphenylmethylindole modulators of PPARG
02/17/2015US8957092 Quinoline derivatives and their use as tyrosine kinase inhibitors
02/17/2015US8957091 Use of quinolinone derivatives as a research tool
02/17/2015US8957090 Fused bicyclic pyridine and pyrazine derivatives as kinase inhibitors
02/17/2015US8957089 Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
02/17/2015US8957088 4-dimethylamino-phenyl-substituted naphthyridines, and use thereof as medicaments
02/17/2015US8957087 Heterocyclic substituted acardite derivate and application thereof
02/17/2015US8957086 Compounds and methods of treating brain disorders
02/17/2015US8957085 Carboxamide bioisosteres of opiates
02/17/2015US8957084 7,8-cyclicmorphinan analogs
02/17/2015US8957082 Tetrahydropyrrolopyrimidinediones and their use in therapy
02/17/2015US8957081 Compounds and compositions as protein kinase inhibitors
02/17/2015US8957080 Tyrosine kinase inhibitors
02/17/2015US8957079 Inhibitors of Bruton's tyrosine kinase
02/17/2015US8957078 Compounds useful as inhibitors of ATR kinase
02/17/2015US8957077 Pyrazolopyrimidine PDE 10 inhibitors
02/17/2015US8957076 Wound healing
02/17/2015US8957075 O-GlcNAc transferase inhibitors and uses thereof
02/17/2015US8957074 Pyrrolopyrimidine compounds as inhibitors of CDK4/6
02/17/2015US8957073 Unsaturated nitrogen heterocyclic compounds useful as PDE10 inhibitors
02/17/2015US8957072 Processes and intermediates in the preparation of morphine analogs via N-demethylation of N-oxides using cyclodehydration reagents
02/17/2015US8957071 Treatment of vascular, autoimmune and inflammatory diseases using low dosages of IMPDH inhibitors
02/17/2015US8957069 Benzofuran derivatives
02/17/2015US8957068 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH
02/17/2015US8957067 Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder
02/17/2015US8957065 Fused pyrimidine derivatives for inhibition of tyrosine kinase activity
02/17/2015US8957064 Fused pyrimidines
02/17/2015US8957063 Amine and ether compounds which modulate the CB2 receptor
02/17/2015US8957061 Azetidine derivatives as sphingosine 1-phosphate (S1P) receptor modulators
02/17/2015US8957060 Tumescent antibiotic solution
02/17/2015US8957059 Modulators of serotonin receptors
02/17/2015US8957058 Insecticidal pyrrolidin-yl-aryl-carboxamides
02/17/2015US8957057 Use of azaphilone compounds for the modulation of the activity of a nuclear hormone receptor
02/17/2015US8957056 Migrastatin analogs in the treatment of cancer
02/17/2015US8957055 Aminoalkylsterol compounds with antitumoral and neuroprotective activity
02/17/2015US8957054 Pharmaceutical compositions
02/17/2015US8957053 Proliposomal testosterone formulations
02/17/2015US8957052 Methods and compositions for the treatment of fluid accumulation in and/or under the retina
02/17/2015US8957051 Bicyclic 1, 2, 4-oxadiazoles derivatives as sphingosine-1 phosphate receptors modulators
02/17/2015US8957049 Inhibitors of fatty acid amide hydrolase
02/17/2015US8957048 Compositions for the treatment of dry eye
02/17/2015US8957047 GLA monotherapy for use in cancer treatment
02/17/2015US8957046 Nucleoside phosphoramidate prodrugs
02/17/2015US8957045 Nucleoside phosphoramidates
02/17/2015US8957038 Treatment of neurological disorders
02/17/2015US8957033 Inhibitor of sodium-dependent glucose transport protein and preparation method therefor and use thereof
02/17/2015US8957027 Deacetylase inhibitor therapy
02/17/2015US8957025 Enkephalin analogues
02/17/2015US8957014 Sensitization of tumor cells to radiation therapy through administration of endothelin agonists
02/17/2015US8957012 Gamma secretase inhibitor for treatment of herpesvirus infection
02/17/2015US8956819 Identification of human mouse double minute 2 homolog nucleotide sequences
02/17/2015US8956682 Hydrophilic polymeric coatings for medical articles with visualization moiety
02/17/2015US8956669 Anticancer and antimicrobial compounds from antarctic extremophilic microorgansims
02/17/2015US8956663 Compositions and methods for treating vaginal infections and pathogenic vaginal biofilms
02/17/2015US8956662 Phenylephrine pharmaceutical formulations and compositions for colonic absorption
02/17/2015US8956659 Fulvestrant nanosphere/microsphere and preparative method and use thereof
1 ... 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 ... 7860